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beings and they should be
stopped immediately.”
Even the broadsheet
newspapers purveyed elements of
sensationalism, while demolishing
it in the same article. The Daily
Telegraph, for example,
highlighted “designer babies” in a
report and headline on the
Newcastle work, based on the
idea of preventing the
transmission of defective
mitochondrial genes.
Yet the article then used helpful
comparisons to repudiate the
nightmare of designer babies.
“These mitochondrial genes make
and run the chemical ‘batteries’
that power body cells,” wrote
science editor Roger Highfield. “In
effect, the new technique would
be like changing a battery in a
computer without affecting the
hard disc.” He also quoted
Newcastle researcher John Burn:
“I would use the analogy of simply
replacing the battery in a pocket
radio…You are not altering the
radio at all, just giving it a new
power source.”
The Daily Express’s approach to
the work mirrored that of Daily
Mail (though it did hedge its bets
by asking “Is this a grotesque
Frankenstein experiment?” rather
asserting as much). In contrast,
The Guardian, The Independent
and The Times were conspicuous
in running clear, cool descriptions
of the technique. Judiciously, The
Guardian concluded with two,
opposing comments. Virginia
Bolton from Guy’s Hospital,
London, pointed out that this was
“yet another example of the value
of human embryo research to
establish the safety of a technique
before it is introduced into clinical
practice.” According to Ms
Quintaville, however, the HFEA
was “turning this country into the
wild west. Whenever they see a
law, they jump through it. Babies
don’t need two mothers.”
Anyone who believes that
tabloid newspapers are
irretrievably wedded to inaccuracy
and hype might be pleasantly
reassured by the Daily Mirror’s
account of the Newcastle
strategy. “Scientists won
permission yesterday to create a
human embryo that will combine
genetic material from two
mothers,” its report read. “They
will transfer the material created
when one woman’s egg and a
man’s sperm fuse – called pro-
nuclei – into another woman’s
unfertilised egg.
“The work…aims to find a way
of preventing mothers passing on
so-called mitochondrial diseases
to their unborn babies. The
diseases are caused by
mitochondrial genes — a small set
of genes outside the nucleus that
can affect more than 50 inherited
diseases. The heart, brain, kidney,
skeletal muscles, liver and
respiratory systems are most
susceptible…About one in 4000
children born each year will
develop a mitochondrial disease
by the age of 10.”
Compare this in tone with the
Daily Express’s treatment of the
parthenogenesis work. Under the
headline “Virgin birth row over
new clone”, the article began
“Scientists sparked outrage
yesterday after performing the
first ‘virgin conception’ in Britain.
In a move which critics
condemned as Frankenstein
science, they have created human
embryos without any genetic
material from a man.” The
account continued: “Campaigners
warned that scientists were
obscuring nature and trying to
play God…Josephine Quintaville,
of Comment on Reproductive
Ethics, said the work was an
outrage.”
Only The Times really
emphasised the principal purpose
of the work. “Dr De Sousa said
that the aim of the research was
to generate embryonic stem (ES)
cells so that their development
could be studied,” wrote science
correspondent Mark Henderson.
“Cells of parthenotes carry errors
in the way genes are switched on
and off, and as this is also a
problem with cloned ES cells
scientists are keen to investigate
further….There is no intention to
implant any parthenogenetic
embryos in women’s wombs.”
Some scientists fail to realise
that journalists have to use drama
and colour to engage readers’
interest in science. But as these
two days illustrated all too vividly,
those qualities are quite distinct
from sensationalism and untruth.
One year ago, Britain’s Wellcome
Trust and Royal Society co-
organised a discussion meeting to
assess the potential dangers
arising from the misuse of
published research results (e.g.
for bioterrorism), and to explore
ways in which the scientific
community might be able to
reduce this risk and alleviate
fears. (Current Biology 2004, 14,
R905).
Now, the first results of the
processes started off by that
meeting have become apparent.
In a joint statement and
accompanying press releases,
three of the main funding
agencies for life science research
in the UK have announced that
they are adjusting their guidelines
and processes to accommodate
provision for misuse risks.
The Medical Research Council
(MRC), the Biotechnology and
Biological Sciences Research
Council (BBSRC), both of which
funnel the UK government’s funds
into research, and the Wellcome
Trust, one of the largest research-
funding charities, acknowledge
the general public’s concern
about potential misuse of life
science research. However, as
BBSRC chief executive Julia
Goodfellow warns, “This risk is
not new, nor is it restricted to high
tech areas of science.” In many
cases, terrorists have used low
tech to devastating effect. Thus,
measures tailored to block misuse
of advanced technology can only
have limited reach.
Colin Blakemore, the MRC chief
executive, said: “Of course, such
measures on their own will not
prevent the efforts of a
determined terrorist, but this is a
positive step by the research
community to raise awareness
and reduce the risks.”
In their joint statement, they
emphasize their view that a
system based on self-governance
by the scientific community will be
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Efforts are growing on the part of
research funders to identify
quickly research topics that may
offer new opportunities for
terrorists. Michael Gross reports.
the most effective way of limiting
the risk. 
Accordingly, the organisations
have agreed to make changes in
four areas:
* Application forms will require
applicants to consider any risks of
misuse linked to the proposed
research.
* Guidance to referees will
contain risk of misuse as a point
that must be considered.
* Guidance for funding
committees will be changed to
include this issue, and to define
procedures to be taken when a
misuse risk is identified.
* Good practice guidelines of
each organisation will be edited to
address misuse possibilities.
Details of how to implement
these changes will be left to the
individual organisations. Each of
them has issued a more detailed
statement on their new policies on
the misuse issue. The BBSRC, for
example, pledges to pay specific
attention to areas not yet included
in existing regulations, including:
* Development of tools that
might have a wide range of
applications.
* Projects that are not
suspicious by themselves, but
might be combined with progress
in other fields, resulting in new
kinds of weapons.
The BBSRC has already set up
a procedure under which any
applications that have raised
concerns under the misuse
policy will be referred to the
BBSRC office, and may be
passed on to the council’s
bioscience for society strategy
panel. But it emphasizes that
“this process does not delay the
funding or the start of the
research.”
However, misuse potential
may only arise during the
research project. The questions
of whether or not to publish
such work was hotly debated at
last year’s discussion meeting.
But the agencies now back free
communication. The BBSRC, for
example, states it “would be
very concerned by any measures
that threatened communication
of research results through
publication.” In agreement with
the US National Academy of
Sciences Committee, the UK
organisations suggest that the
dissemination of research
results should continue to be
based on the voluntary
self-governance by the scientific
community.
One last thorny issue that was
raised in the discussions on this
topic is the dissemination of
knowledge by movement of
research students or workers
between countries. In some
quarters, there are fears that
people with undesirable
intentions might sign up for
doctoral or post-doctoral work in
the leading scientific nations, and
later apply the acquired
knowledge to nefarious use.
There have already been reports
suggesting that scientists from a
range of countries are now
finding it more difficult to enter
the US for research work.
But the BBSRC states that “it
would be concerned by any
extension of existing regulations
that would disproportionately
restrict the international exchange
of materials and the ability of
overseas scientists to work in the
UK or for UK researchers to
collaborate with researchers
overseas.”
Michael Gross is a science writer based
at Oxford. He can be contacted via his
web page at
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Biohazard: Research on materials known to be of a potential bioterrorism risk is well regulated but funding bodies are putting in
place measures to monitor unexpected research developments that might be put to such use. (Photograph: Philippe Plailly/Eurelios/
Science Photo Library.) 
